REPLY: Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs

被引：0
|
作者：
Kramer, Caroline K. [1 ]
Ye, Chang [1 ]
Retnakaran, Ravi [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St,Suite L5-025,Mailbox 21, Toronto, ON M5T 3L9, Canada
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 12期
关键词：
D O I：
10.1016/j.jchf.2018.10.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1052 / 1053
页数：2
相关论文
共 50 条
  • [31] Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
    Ghosh-Swaby, Olivia R.
    Goodman, Shaun G.
    Leiter, Lawrence A.
    Cheng, Alice
    Connelly, Kim A.
    Fitchett, David
    Juni, Peter
    Farkouh, Michael E.
    Udell, Jacob A.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (05): : 418 - 435
  • [32] Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Cattadori, Gaia
    Pantanetti, Paola
    Ambrosio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
  • [33] Design and Analysis of Diabetes Prevention Trials for Glucose-Lowering Drugs
    Holzhauer, Bjoern
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2014, 6 (01): : 104 - 114
  • [34] Cardiovascular safety concerns of glucose-lowering drugs
    Scholze J.
    MMW - Fortschritte der Medizin, 2017, 159 (1) : 62 - 66
  • [35] Cardiorenal Benefits of Newer Glucose-Lowering Drugs by Hispanic Ethnicity: A Meta-analysis of Results from Randomized Outcome Trials in Type 2 Diabetes
    Tang, Huilin
    Chen, Wei-Han
    Bian, Jiang
    O'Neal, Latoya J.
    Lackland, Daniel T.
    Schatz, Desmond
    Guo, Jingchuan
    DIABETES, 2022, 71
  • [36] Perioperative Management of Glucose-lowering Drugs: Reply
    Preiser, Jean-Charles
    Cnop, Miriam
    ANESTHESIOLOGY, 2021, 134 (02) : 350 - 351
  • [37] Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
    Gerstein, Hertzel C.
    Shah, Reema
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 97 - +
  • [38] Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes A Network Meta-Analysis
    Kramer, Caroline K.
    Ye, Chang
    Campbell, Sara
    Retnakaran, Ravi
    JACC-HEART FAILURE, 2018, 6 (10) : 823 - 830
  • [39] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes REPLY
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 671 - 672
  • [40] Effects of novel glucose-lowering drugs on the lipid parameters: A systematic review and meta-analysis
    Dar, Sophia
    Siddiqi, Ahmed Kamal
    Alabduladhem, Tamim Omar
    Rashid, Ahmed Mustafa
    Sarfraz, Saba
    Maniya, Talha
    Menezes, Ritesh G.
    Almas, Talal
    ANNALS OF MEDICINE AND SURGERY, 2022, 77
12345